Related Experiment Video
Updated: Feb 2, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Genetic regulation of longevity and age-associated diseases through the methionine sulfoxide reductase system
Derek B Oien1, Jackob Moskovitz2
1Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States of America.
Abstract:
Methionine sulfoxide reductase enzymes are a protective system against biological oxidative stress in aerobic organisms. Modifications to this antioxidant system have been shown to impact the lifespan of several model system organisms. In humans, methionine oxidation of critical proteins and deficiencies in the methionine sulfoxide reductase system have been linked to age-related diseases, including cancer and neurodegenerative disease. Substrates for methionine sulfoxide reductases have been reviewed multiple times, and are still an active area of discovery. In contrast, less is known about the genetic regulation of methionine sulfoxide reductases. In this review, we discuss studies on the genetic regulation of the methionine sulfoxide reductase system with relevance to longevity and age-related diseases. A better understanding of genetic regulation for methionine sulfoxide reductases may lead to new therapeutic approaches for age-related diseases in the future.
More Related Videos
Related Concept Videos
Epigenetic Regulation
What is Genetic Engineering?
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Genetics of Speciation
What is Population Genetics?
GTPases and their Regulation
Large G-proteins,...

